Blockade of miR-150 Maturation by MLL-Fusion/MYC/LIN-28 Is Required for MLL-Associated Leukemia
- 1 October 2012
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 22 (4) , 524-535
Abstract
No abstract availableKeywords
Funding Information
- American Cancer Society
- National Human Genome Research Institute (P01 CA40046, P30 CA014599)
- Leukemia and Lymphoma Society
- Fidelity Foundation (R01 HL95896)
- University of Chicago
- National Institutes of Health (CA127277)
- Gabrielle’s Angel Foundation for Cancer Research
This publication has 50 references indexed in Scilit:
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- Posttranscriptional Regulation of MicroRNA Biogenesis in AnimalsMolecular Cell, 2010
- Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem CellsCell Stem Cell, 2009
- MicroRNA Control in the Immune System: Basic PrinciplesCell, 2009
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 LeukemiasCancer Cell, 2008
- Lin28 Mediates the Terminal Uridylation of let-7 Precursor MicroRNAMolecular Cell, 2008
- MicroRNA-Mediated Control of Cell Fate in Megakaryocyte-Erythrocyte ProgenitorsDevelopmental Cell, 2008
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005